A doctor might recommend adding rapid insulin before a meal to prevent a blood sugar spike after you eat. If you change brands of long-acting insulin, you may need a different dose. Talk to a ...
Sanofi’s Admelog (insulin lispro) is approved in type 1 and type 2 diabetes as a follow-on drug to Humalog, a rapid-acting insulin ... alternatives to brand name drugs approved through the ...
It is the first biosimilar of a rapid-acting insulin ... $35 monthly insulin copay cap for Medicare. While a few years ago, the loss of patent protection for a big insulin brand would have been ...
WEDNESDAY, Feb. 19, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric ...
Merilog is a rapid-acting human insulin analog and the first rapid-acting insulin biosimilar product approved by the FDA. Administering Merilog subcutaneously five to 10 minutes before mealtime ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results